Ruti Aga: How a Forged Prescription Became a Six-Year Ban — and Why the Media Called a Glucocorticoid a 'Steroid'

One night in March, at a label half marathon in China, Ruti Aga crossed the line first. No splits, no sector times, just a win — and a sample collected after it. She has been provisionally suspended since 10 September, and now the Athletics Integrity Unit (AIU) has handed down a six-year ban. For a 32-year-old marathoner, that is career death. But the real story is not the substance found in her body. It is the document she produced, and the sentence she spoke during the investigation.

First, a technical correction, because the entire case hinges on it. British media described methylprednisolone as a 'prohibited steroid' and wrote that WADA classes it as performance-enhancing. That is wrong. Methylprednisolone is a glucocorticoid — class S9 on the WADA Prohibited List — not an anabolic steroid (S1). And the most important condition of S9 is this: it is prohibited only in-competition, and only by injection, oral or rectal routes. A therapeutic knee injection given out-of-competition is entirely legal. It becomes a violation only if residues are still present in-competition.

I found the whole argument hiding in a 0.01-second replay — except here the interval is not seconds but dates. According to the AIU statement, Aga cited a knee injury. Intra-articular methylprednisolone for knee synovitis is standard sports-medicine practice in distance runners. That is the bitterest irony of this case: the defence that was legitimate, she destroyed with a forged document. Real records would have made the defence strong. Instead, the prescription presented came from a clinic that did not exist, written by a family member with no medical registration, who claimed he had used 'an old prescription pad from a former workplace.' The clinic explicitly disowned it. Three independent verification failures — not one.

Now look at the arithmetic, because the structure of the sanction is the real lesson. Two years for the presence violation — the standard sanction in 'Specified Substance' cases where intent is not proven — and four years for tampering, the Code's standard penalty. Add them: six years. That sum tells us directly that the panel rejected the 'no significant fault' mitigation. Had she not forged the prescription, even the two-year ban might have been reduced to a reprimand or a far shorter period. The forged document burned the one escape route that could actually have worked.

Backdating to 10 September sounds like relief, but it isn't. Time served under provisional suspension counts against the ban — the athlete gains nothing in real terms. And the real question is what a six-year ban means at 32. She will be nearly 38 when she returns. Ethiopia's women's marathon depth is so extreme that a 2:18–2:20 performer is not automatically selected for the national team — and a 38-year-old returnee with a doping record is effectively unselectable. On paper the ban is six years; in practice it is a lifetime.

Here is a fact the media dropped: her 2026 Tokyo Marathon title and three second-place finishes at World Marathon Majors all predate that March race. Absent proof of earlier use, those results are not automatically annulled. The scope of this case is limited to that March race — its result and prize money will almost certainly be voided, but the 2026 title will not. That distinction matters, because it shows what the punishment is attached to: not performance, but process.

Now the part where I think the biggest story is being missed. No athlete forges a prescription on their own. Aga's case is not isolated — it belongs to a new frontier of document verification in East African road racing, where an initial substance violation is compounded by a fabricated explanation. I think the trap is this: reading this case as either 'AIU rigour' or 'inconsistent enforcement against African runners' is equally incomplete. The real question is: why couldn't a 32-year-old elite marathoner get a credentialed team doctor for a knee injection? The answer lies in the ecosystem that produces these runners — agent-based, appearance-fee driven, where there is pressure to hide injury because missing a race means missing income, and where informal networks substitute for formal medical support. The forged prescription grew in that empty space.

Here is my counter-intuitive conclusion, and I am writing it only after checking it against the timing sheet: a six-year ban has been imposed for a glucocorticoid, a substance with no proven endurance benefit. This number will be cited on both sides — as evidence of AIU rigour, and as a question about whether the weight of the sanction rests on the substance or on the document. I believe that question cannot be dodged, because if the real basis of the sanction is a forged document, then we must say clearly: this is less a doping case and more a case of medical-governance failure.

And that is my biggest concern. When an athlete forges a prescription, the athlete is punished. But the system that pushed her there — no credentialed physician, no TUE process, and economic pressure to hide injury — remains in place. The next Ruti Aga will be on the same path.

The question is not whether six years is too much or too little. The question is: the next knee injury — whose door will it go to? A credentialed doctor's, or a family member's old prescription pad?